BGLAP and metabolic syndrome: In the ALN group, the prevalence of dyslipidemia (OR: 0.40, 95% CI: 0.20–0.79, p = 0.01), MMSE (OR: 0.92, 95% CI: 0.87–0.97, p < 0.01), weight (OR: 0.97, 95% CI: 0.95–1.00, p = 0.04), and osteocalcin (OR: 1.02, 95% CI: 1.00–1.04, p = 0.05) were significantly associated with compliance-related discontinuation.